drugset / Trial / NCT06946615
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of Claudin18.2-targeted CAR-DC combined with CAR-T cell therapy in patients with advanced colorectal cancer.
Timeline
- Start
- 2025-04-08
- Primary completion
- 2026-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Claudin18.2 Targeted CAR-T Cells | Cell therapy | — | — |
| Subject | Claudin18.2-targeted CAR-DCs | Cell therapy | — | — |